Medical Supplies and Services News

AUDUBON, Pa., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and...

BEDFORD, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue...

Il Consiglio di Amministrazione di EssilorLuxottica propone il rinnovo di otto Amministratori Parigi, Francia (11 febbraio 2026 – ore 18:00) – Il Consiglio di Amministrazione di EssilorLuxottica si è...

Le Conseil d’administration d’EssilorLuxottica propose la nomination de huit administrateurs et administratrices Paris, France (11 février 2026 – 18h00) – Réuni aujourd’hui, le Conseil...

EssilorLuxottica Board of Directors Proposes Renewal of Eight Directors Paris, France (11 February 2026 – 6:00pm) – During its meeting today, EssilorLuxottica Board of Directors decided to propose to...

Fatturato1 in crescita del 18,4% nel quarto trimestre e dell’11,2% nel 2025 Margine operativo adjusted1,2 a 16,0% nel 2025 Fatturato del Gruppo a 28.491 milioni di Euro nel 2025, in crescita...

Hausse de +18,4 % du chiffre d'affaires1 au T4 et de +11,2 % sur l'exercice Marge opérationnelle ajustée1,2 à 16,0 % sur l'exercice Chiffre d’affaires annuel du Groupe à 28 491 millions d’euros,...

Revenue1 growing 18.4% in Q4 and 11.2% in the FY Adj. operating margin1,2 at 16.0% in the FY Group’s revenue at Euro 28,491 million in the FY, +11.2% at constant exchange rates1, with Q4 at...

Venligst se vedlagte pdf.  Opdatering af datoer i finanskalenderen Coloplast har opdateret datoerne i selskabets finanskalender vedrørende offentliggørelsen af årsregnskabet for 2025/26 samt...

Please see enclosed pdf. Update to Financial Calendar Dates Coloplast has updated the dates in its financial calendar for the publication of the FY Financial Statements 2025/26 and the Annual...